Oculis Statistics
NASDAQ: OCSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.50-0.22 (-2.52%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Oculis by the numbers
Oculis has a market capitalization of $523.5 million based on 61.59M shares outstanding. With trailing EPS of $-1.74, Oculis is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.2% below its 50-day average and 57.5% below its 200-day average.
Average daily trading volume is 259.47K shares, or about $2.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OCS valuation vs. peer median
| Metric | OCS | Peer median | Difference |
|---|---|---|---|
| Market cap | $523.50M | $515.17M | +2% |
| Avg. volume | 259.47K | 354.38K | -27% |
Peer median across 8 companies: MPLT, BLSM, NGNE, ALT, DRUG, EOLS, PBYI, CBIO.
Valuation
- Market cap
- $523.50M
- EPS (TTM)
- $-1.74
- Shares outstanding
- 61.59M
Price and trading
- Previous close
- 8.72
- Open
- 8.83
- Day range
- 8.36 – 8.83
- 52-week range
- 8.30 – 34.48
- 52-week change
- -55.40%
- Beta
- —
- Volume
- 173.68K
- Average volume
- 259.47K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 523.50M
- Forward Pe
- -4.29
- Eps
- -1.74
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 34.48
- Week52 Low
- 8.30
- Avg Volume
- 259.47K
- Shares Outstanding
- 61.59M
- Ma50
- 11.37
- Ma200
- 20.01
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -75.34%
- Pct From52w Low
- 2.41%